drugset / Trial / NCT03424824

Randomized Clinical Trial Evaluating BP1.3656 Versus Placebo For Alcohol Use Disorder Treatment

NCT03424824 ↗

Phase 2 Completed 210 enrolled Bioprojet
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A Multisite Randomized Clinical Trial Evaluating BP1.3656 Vs Placebo For Alcohol Use Disorder Treatment.

Timeline

Start
2018-01-09
Primary completion
2021-11-24
Completion
2021-11-24

Drugs

EvaluationDrugModalityDoseRoute
Subject BP1.3656 Unknown 30 ug Oral
Subject BP1.3656 Unknown 60 ug Oral
Subject BP1.3656 Unknown 90 ug Oral